Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ATF2
|
ENSG00000115966.12 | activating transcription factor 2 |
ATF1
|
ENSG00000123268.4 | activating transcription factor 1 |
ATF3
|
ENSG00000162772.12 | activating transcription factor 3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ATF3 | hg19_v2_chr1_+_212782012_212782257 | -0.67 | 2.4e-05 | Click! |
ATF1 | hg19_v2_chr12_+_51158263_51158395 | 0.26 | 1.5e-01 | Click! |
ATF2 | hg19_v2_chr2_-_176032843_176032941 | -0.18 | 3.2e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_+_139456226 | 7.91 |
ENST00000367658.2
|
HECA
|
headcase homolog (Drosophila) |
chr19_+_1941117 | 4.95 |
ENST00000255641.8
|
CSNK1G2
|
casein kinase 1, gamma 2 |
chr5_-_175965008 | 4.89 |
ENST00000537487.1
|
RNF44
|
ring finger protein 44 |
chr7_-_105926058 | 4.36 |
ENST00000417537.1
|
NAMPT
|
nicotinamide phosphoribosyltransferase |
chr19_-_46088068 | 4.31 |
ENST00000263275.4
ENST00000323060.3 |
OPA3
|
optic atrophy 3 (autosomal recessive, with chorea and spastic paraplegia) |
chr11_-_77185094 | 4.31 |
ENST00000278568.4
ENST00000356341.3 |
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1 |
chr7_-_142120321 | 4.21 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
chr7_-_140624499 | 3.96 |
ENST00000288602.6
|
BRAF
|
v-raf murine sarcoma viral oncogene homolog B |
chr7_+_142031986 | 3.94 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr6_-_34664612 | 3.84 |
ENST00000374023.3
ENST00000374026.3 |
C6orf106
|
chromosome 6 open reading frame 106 |
chr7_-_142099977 | 3.66 |
ENST00000390359.3
|
TRBV7-8
|
T cell receptor beta variable 7-8 |
chr12_-_92539614 | 3.57 |
ENST00000256015.3
|
BTG1
|
B-cell translocation gene 1, anti-proliferative |
chr15_+_76629064 | 3.56 |
ENST00000290759.4
|
ISL2
|
ISL LIM homeobox 2 |
chr14_+_68086515 | 3.23 |
ENST00000261783.3
|
ARG2
|
arginase 2 |
chr14_+_22180536 | 3.20 |
ENST00000390424.2
|
TRAV2
|
T cell receptor alpha variable 2 |
chr22_+_44568825 | 3.08 |
ENST00000422871.1
|
PARVG
|
parvin, gamma |
chrX_+_49832231 | 3.03 |
ENST00000376108.3
|
CLCN5
|
chloride channel, voltage-sensitive 5 |
chr7_-_142149390 | 3.02 |
ENST00000390372.3
|
TRBV5-5
|
T cell receptor beta variable 5-5 |
chr18_+_61554932 | 2.98 |
ENST00000299502.4
ENST00000457692.1 ENST00000413956.1 |
SERPINB2
|
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chr7_+_142020496 | 2.94 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
chr7_-_142247606 | 2.93 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
chr8_+_42195972 | 2.88 |
ENST00000532157.1
ENST00000265421.4 ENST00000520008.1 |
POLB
|
polymerase (DNA directed), beta |
chr7_-_142232071 | 2.85 |
ENST00000390364.3
|
TRBV10-1
|
T cell receptor beta variable 10-1(gene/pseudogene) |
chr19_-_47616992 | 2.78 |
ENST00000253048.5
|
ZC3H4
|
zinc finger CCCH-type containing 4 |
chr1_-_26701003 | 2.77 |
ENST00000455900.1
|
ZNF683
|
zinc finger protein 683 |
chr19_-_48547294 | 2.74 |
ENST00000293255.2
|
CABP5
|
calcium binding protein 5 |
chr3_+_38206975 | 2.72 |
ENST00000446845.1
ENST00000311806.3 |
OXSR1
|
oxidative stress responsive 1 |
chr12_+_56511943 | 2.71 |
ENST00000257940.2
ENST00000552345.1 ENST00000551880.1 ENST00000546903.1 ENST00000551790.1 |
ZC3H10
ESYT1
|
zinc finger CCCH-type containing 10 extended synaptotagmin-like protein 1 |
chr5_-_172198190 | 2.70 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr19_+_1954632 | 2.66 |
ENST00000589350.1
|
CSNK1G2
|
casein kinase 1, gamma 2 |
chr7_-_142111859 | 2.62 |
ENST00000390378.1
|
TRBV5-7
|
T cell receptor beta variable 5-7 (non-functional) |
chr6_+_15249128 | 2.59 |
ENST00000397311.3
|
JARID2
|
jumonji, AT rich interactive domain 2 |
chr3_+_16306691 | 2.58 |
ENST00000285083.5
ENST00000605932.1 ENST00000435829.2 |
OXNAD1
|
oxidoreductase NAD-binding domain containing 1 |
chr9_+_116298778 | 2.56 |
ENST00000462143.1
|
RGS3
|
regulator of G-protein signaling 3 |
chr12_-_107168696 | 2.55 |
ENST00000551505.1
|
RP11-144F15.1
|
Uncharacterized protein |
chr11_-_3818688 | 2.54 |
ENST00000355260.3
ENST00000397004.4 ENST00000397007.4 ENST00000532475.1 |
NUP98
|
nucleoporin 98kDa |
chr7_-_142131914 | 2.50 |
ENST00000390375.2
|
TRBV5-6
|
T cell receptor beta variable 5-6 |
chr6_-_41254403 | 2.47 |
ENST00000589614.1
ENST00000334475.6 ENST00000591620.1 ENST00000244709.4 |
TREM1
|
triggering receptor expressed on myeloid cells 1 |
chr2_+_30454390 | 2.45 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr17_-_4890649 | 2.44 |
ENST00000361571.5
|
CAMTA2
|
calmodulin binding transcription activator 2 |
chr8_+_42196000 | 2.42 |
ENST00000518925.1
ENST00000538005.1 |
POLB
|
polymerase (DNA directed), beta |
chr5_+_172332220 | 2.41 |
ENST00000518247.1
ENST00000326654.2 |
ERGIC1
|
endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
chr12_-_64616019 | 2.39 |
ENST00000311915.8
ENST00000398055.3 ENST00000544871.1 |
C12orf66
|
chromosome 12 open reading frame 66 |
chr14_-_50053081 | 2.39 |
ENST00000396020.3
ENST00000245458.6 |
RPS29
|
ribosomal protein S29 |
chr14_-_55369525 | 2.36 |
ENST00000543643.2
ENST00000536224.2 ENST00000395514.1 ENST00000491895.2 |
GCH1
|
GTP cyclohydrolase 1 |
chr5_-_99870932 | 2.36 |
ENST00000504833.1
|
CTD-2001C12.1
|
CTD-2001C12.1 |
chr11_+_128563652 | 2.30 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr6_-_91006627 | 2.30 |
ENST00000537989.1
|
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr19_-_51014460 | 2.28 |
ENST00000595669.1
|
JOSD2
|
Josephin domain containing 2 |
chrX_+_10126488 | 2.27 |
ENST00000380829.1
ENST00000421085.2 ENST00000454850.1 |
CLCN4
|
chloride channel, voltage-sensitive 4 |
chr19_+_50979753 | 2.26 |
ENST00000597426.1
ENST00000334976.6 ENST00000376918.3 ENST00000598585.1 |
EMC10
|
ER membrane protein complex subunit 10 |
chr18_+_77155856 | 2.26 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr7_-_142240014 | 2.21 |
ENST00000390363.2
|
TRBV9
|
T cell receptor beta variable 9 |
chr16_+_50775948 | 2.18 |
ENST00000569681.1
ENST00000569418.1 ENST00000540145.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr6_-_91006461 | 2.16 |
ENST00000257749.4
ENST00000343122.3 ENST00000406998.2 ENST00000453877.1 |
BACH2
|
BTB and CNC homology 1, basic leucine zipper transcription factor 2 |
chr7_-_142176790 | 2.14 |
ENST00000390369.2
|
TRBV7-4
|
T cell receptor beta variable 7-4 (gene/pseudogene) |
chr19_+_1065922 | 2.13 |
ENST00000539243.2
|
HMHA1
|
histocompatibility (minor) HA-1 |
chr11_-_3818932 | 2.12 |
ENST00000324932.7
ENST00000359171.4 |
NUP98
|
nucleoporin 98kDa |
chr12_-_12715266 | 2.11 |
ENST00000228862.2
|
DUSP16
|
dual specificity phosphatase 16 |
chr8_+_126442563 | 2.10 |
ENST00000311922.3
|
TRIB1
|
tribbles pseudokinase 1 |
chr6_+_64281906 | 2.10 |
ENST00000370651.3
|
PTP4A1
|
protein tyrosine phosphatase type IVA, member 1 |
chr8_-_17104099 | 2.10 |
ENST00000524358.1
|
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
chr2_-_74781061 | 2.08 |
ENST00000264094.3
ENST00000393937.2 ENST00000409986.1 |
LOXL3
|
lysyl oxidase-like 3 |
chr7_-_129592700 | 2.08 |
ENST00000472396.1
ENST00000355621.3 |
UBE2H
|
ubiquitin-conjugating enzyme E2H |
chr12_-_123380610 | 2.07 |
ENST00000535765.1
|
VPS37B
|
vacuolar protein sorting 37 homolog B (S. cerevisiae) |
chr2_-_202645612 | 2.06 |
ENST00000409632.2
ENST00000410052.1 ENST00000467448.1 |
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile) |
chr3_+_16306837 | 2.05 |
ENST00000606098.1
|
OXNAD1
|
oxidoreductase NAD-binding domain containing 1 |
chrX_+_12993202 | 2.04 |
ENST00000451311.2
ENST00000380636.1 |
TMSB4X
|
thymosin beta 4, X-linked |
chr8_+_38243721 | 2.02 |
ENST00000527334.1
|
LETM2
|
leucine zipper-EF-hand containing transmembrane protein 2 |
chr5_+_133707252 | 2.01 |
ENST00000506787.1
ENST00000507277.1 |
UBE2B
|
ubiquitin-conjugating enzyme E2B |
chr12_+_9066472 | 2.01 |
ENST00000538657.1
|
PHC1
|
polyhomeotic homolog 1 (Drosophila) |
chr12_+_22778291 | 2.01 |
ENST00000545979.1
|
ETNK1
|
ethanolamine kinase 1 |
chr2_+_70142189 | 1.99 |
ENST00000264444.2
|
MXD1
|
MAX dimerization protein 1 |
chr7_-_142169013 | 1.98 |
ENST00000454561.2
|
TRBV5-4
|
T cell receptor beta variable 5-4 |
chr11_+_117049854 | 1.98 |
ENST00000278951.7
|
SIDT2
|
SID1 transmembrane family, member 2 |
chr19_-_51014345 | 1.96 |
ENST00000391815.3
ENST00000594350.1 ENST00000601423.1 |
JOSD2
|
Josephin domain containing 2 |
chr2_-_145188137 | 1.95 |
ENST00000440875.1
|
ZEB2
|
zinc finger E-box binding homeobox 2 |
chr8_-_66754172 | 1.95 |
ENST00000401827.3
|
PDE7A
|
phosphodiesterase 7A |
chr6_-_38607673 | 1.93 |
ENST00000481247.1
|
BTBD9
|
BTB (POZ) domain containing 9 |
chr17_-_4890919 | 1.91 |
ENST00000572543.1
ENST00000381311.5 ENST00000348066.3 ENST00000358183.4 |
CAMTA2
|
calmodulin binding transcription activator 2 |
chr22_+_25003568 | 1.91 |
ENST00000447416.1
|
GGT1
|
gamma-glutamyltransferase 1 |
chr4_+_170581213 | 1.90 |
ENST00000507875.1
|
CLCN3
|
chloride channel, voltage-sensitive 3 |
chr20_+_33292507 | 1.89 |
ENST00000414082.1
|
TP53INP2
|
tumor protein p53 inducible nuclear protein 2 |
chr1_+_203274639 | 1.88 |
ENST00000290551.4
|
BTG2
|
BTG family, member 2 |
chr19_+_24009879 | 1.88 |
ENST00000354585.4
|
RPSAP58
|
ribosomal protein SA pseudogene 58 |
chr13_+_111767650 | 1.85 |
ENST00000449979.1
ENST00000370623.3 |
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
chr2_+_219745020 | 1.84 |
ENST00000258411.3
|
WNT10A
|
wingless-type MMTV integration site family, member 10A |
chr14_+_21498666 | 1.84 |
ENST00000481535.1
|
TPPP2
|
tubulin polymerization-promoting protein family member 2 |
chr3_-_101395936 | 1.83 |
ENST00000461821.1
|
ZBTB11
|
zinc finger and BTB domain containing 11 |
chr6_+_35227247 | 1.83 |
ENST00000469195.1
|
ZNF76
|
zinc finger protein 76 |
chr22_+_25003606 | 1.83 |
ENST00000432867.1
|
GGT1
|
gamma-glutamyltransferase 1 |
chr18_+_77155942 | 1.82 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr7_+_89975979 | 1.82 |
ENST00000257659.8
ENST00000222511.6 ENST00000417207.1 |
GTPBP10
|
GTP-binding protein 10 (putative) |
chr11_-_6633799 | 1.81 |
ENST00000299424.4
|
TAF10
|
TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa |
chr5_-_16509101 | 1.81 |
ENST00000399793.2
|
FAM134B
|
family with sequence similarity 134, member B |
chr17_+_55333876 | 1.80 |
ENST00000284073.2
|
MSI2
|
musashi RNA-binding protein 2 |
chr20_+_44420570 | 1.78 |
ENST00000372622.3
|
DNTTIP1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
chr17_-_8151353 | 1.78 |
ENST00000315684.8
|
CTC1
|
CTS telomere maintenance complex component 1 |
chr16_+_68056844 | 1.77 |
ENST00000565263.1
|
DUS2
|
dihydrouridine synthase 2 |
chr22_-_39096981 | 1.77 |
ENST00000427389.1
|
JOSD1
|
Josephin domain containing 1 |
chr16_+_50776021 | 1.77 |
ENST00000566679.2
ENST00000564634.1 ENST00000398568.2 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr14_+_22314715 | 1.76 |
ENST00000390434.3
|
TRAV8-2
|
T cell receptor alpha variable 8-2 |
chr1_+_39456895 | 1.76 |
ENST00000432648.3
ENST00000446189.2 ENST00000372984.4 |
AKIRIN1
|
akirin 1 |
chr12_+_56521840 | 1.75 |
ENST00000394048.5
|
ESYT1
|
extended synaptotagmin-like protein 1 |
chr2_+_70142232 | 1.75 |
ENST00000540449.1
|
MXD1
|
MAX dimerization protein 1 |
chr11_-_65429891 | 1.75 |
ENST00000527874.1
|
RELA
|
v-rel avian reticuloendotheliosis viral oncogene homolog A |
chr18_+_57567180 | 1.74 |
ENST00000316660.6
ENST00000269518.9 |
PMAIP1
|
phorbol-12-myristate-13-acetate-induced protein 1 |
chr7_-_142198049 | 1.73 |
ENST00000471935.1
|
TRBV11-2
|
T cell receptor beta variable 11-2 |
chr5_-_133304473 | 1.72 |
ENST00000231512.3
|
C5orf15
|
chromosome 5 open reading frame 15 |
chr15_-_55700457 | 1.72 |
ENST00000442196.3
ENST00000563171.1 ENST00000425574.3 |
CCPG1
|
cell cycle progression 1 |
chr8_-_116681686 | 1.71 |
ENST00000519815.1
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr17_+_73089382 | 1.71 |
ENST00000538213.2
ENST00000584118.1 |
SLC16A5
|
solute carrier family 16 (monocarboxylate transporter), member 5 |
chr5_+_148206156 | 1.70 |
ENST00000305988.4
|
ADRB2
|
adrenoceptor beta 2, surface |
chr17_-_7155775 | 1.69 |
ENST00000571409.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr22_+_25003626 | 1.69 |
ENST00000451366.1
ENST00000406383.2 ENST00000428855.1 |
GGT1
|
gamma-glutamyltransferase 1 |
chrX_+_155110956 | 1.69 |
ENST00000286448.6
ENST00000262640.6 ENST00000460621.1 |
VAMP7
|
vesicle-associated membrane protein 7 |
chr17_-_77813186 | 1.68 |
ENST00000448310.1
ENST00000269397.4 |
CBX4
|
chromobox homolog 4 |
chr17_-_40540586 | 1.68 |
ENST00000264657.5
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
chr19_-_51014588 | 1.68 |
ENST00000598418.1
|
JOSD2
|
Josephin domain containing 2 |
chrX_+_12993336 | 1.67 |
ENST00000380635.1
|
TMSB4X
|
thymosin beta 4, X-linked |
chr10_+_99079008 | 1.66 |
ENST00000371021.3
|
FRAT1
|
frequently rearranged in advanced T-cell lymphomas |
chr16_+_68057153 | 1.65 |
ENST00000358896.6
ENST00000568099.2 |
DUS2
|
dihydrouridine synthase 2 |
chr16_+_30087288 | 1.65 |
ENST00000279387.7
ENST00000562664.1 ENST00000562222.1 |
PPP4C
|
protein phosphatase 4, catalytic subunit |
chr20_+_44420617 | 1.64 |
ENST00000449078.1
ENST00000456939.1 |
DNTTIP1
|
deoxynucleotidyltransferase, terminal, interacting protein 1 |
chr8_-_17103951 | 1.63 |
ENST00000520178.1
|
CNOT7
|
CCR4-NOT transcription complex, subunit 7 |
chrY_-_15591818 | 1.62 |
ENST00000382893.1
|
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
chr2_+_28113583 | 1.62 |
ENST00000344773.2
ENST00000379624.1 ENST00000342045.2 ENST00000379632.2 ENST00000361704.2 |
BRE
|
brain and reproductive organ-expressed (TNFRSF1A modulator) |
chr11_-_47400062 | 1.62 |
ENST00000533030.1
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr3_-_52312337 | 1.61 |
ENST00000469000.1
|
WDR82
|
WD repeat domain 82 |
chr2_+_135596106 | 1.61 |
ENST00000356140.5
|
ACMSD
|
aminocarboxymuconate semialdehyde decarboxylase |
chr1_-_86861660 | 1.61 |
ENST00000486215.1
|
ODF2L
|
outer dense fiber of sperm tails 2-like |
chr6_-_38607628 | 1.60 |
ENST00000498633.1
|
BTBD9
|
BTB (POZ) domain containing 9 |
chr19_-_50528392 | 1.59 |
ENST00000600137.1
ENST00000597215.1 |
VRK3
|
vaccinia related kinase 3 |
chr3_+_42190714 | 1.58 |
ENST00000449246.1
|
TRAK1
|
trafficking protein, kinesin binding 1 |
chr1_+_174933899 | 1.58 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chr14_+_22891362 | 1.57 |
ENST00000390469.2
|
TRDV2
|
T cell receptor delta variable 2 |
chr19_-_10341948 | 1.57 |
ENST00000590320.1
ENST00000592342.1 ENST00000588952.1 |
S1PR2
DNMT1
|
sphingosine-1-phosphate receptor 2 DNA (cytosine-5-)-methyltransferase 1 |
chr17_-_4643114 | 1.57 |
ENST00000293778.6
|
CXCL16
|
chemokine (C-X-C motif) ligand 16 |
chr17_-_43568062 | 1.56 |
ENST00000421073.2
ENST00000584420.1 ENST00000589780.1 ENST00000430334.3 |
PLEKHM1
|
pleckstrin homology domain containing, family M (with RUN domain) member 1 |
chr1_-_47184745 | 1.56 |
ENST00000544071.1
|
EFCAB14
|
EF-hand calcium binding domain 14 |
chr6_+_30029008 | 1.55 |
ENST00000332435.5
ENST00000376782.2 ENST00000359374.4 ENST00000376785.2 |
ZNRD1
|
zinc ribbon domain containing 1 |
chr9_-_86322831 | 1.55 |
ENST00000257468.7
|
UBQLN1
|
ubiquilin 1 |
chr7_+_44646177 | 1.54 |
ENST00000443864.2
ENST00000447398.1 ENST00000449767.1 ENST00000419661.1 |
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr7_+_44646162 | 1.54 |
ENST00000439616.2
|
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr1_+_26496362 | 1.54 |
ENST00000374266.5
ENST00000270812.5 |
ZNF593
|
zinc finger protein 593 |
chr19_+_18283959 | 1.53 |
ENST00000597802.2
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr16_+_50775971 | 1.52 |
ENST00000311559.9
ENST00000564326.1 ENST00000566206.1 |
CYLD
|
cylindromatosis (turban tumor syndrome) |
chr14_+_50359773 | 1.52 |
ENST00000298316.5
|
ARF6
|
ADP-ribosylation factor 6 |
chrX_-_106960285 | 1.52 |
ENST00000503515.1
ENST00000372397.2 |
TSC22D3
|
TSC22 domain family, member 3 |
chr4_-_104119488 | 1.52 |
ENST00000514974.1
|
CENPE
|
centromere protein E, 312kDa |
chr20_+_30697298 | 1.52 |
ENST00000398022.2
|
TM9SF4
|
transmembrane 9 superfamily protein member 4 |
chr1_+_29213678 | 1.52 |
ENST00000347529.3
|
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
chr3_-_71632894 | 1.51 |
ENST00000493089.1
|
FOXP1
|
forkhead box P1 |
chr3_+_43328004 | 1.51 |
ENST00000454177.1
ENST00000429705.2 ENST00000296088.7 ENST00000437827.1 |
SNRK
|
SNF related kinase |
chr3_+_170075436 | 1.51 |
ENST00000476188.1
ENST00000259119.4 ENST00000426052.2 |
SKIL
|
SKI-like oncogene |
chr5_+_138210919 | 1.51 |
ENST00000522013.1
ENST00000520260.1 ENST00000523298.1 ENST00000520865.1 ENST00000519634.1 ENST00000517533.1 ENST00000523685.1 ENST00000519768.1 ENST00000517656.1 ENST00000521683.1 ENST00000521640.1 ENST00000519116.1 |
CTNNA1
|
catenin (cadherin-associated protein), alpha 1, 102kDa |
chr12_+_75874984 | 1.51 |
ENST00000550491.1
|
GLIPR1
|
GLI pathogenesis-related 1 |
chr9_-_77643189 | 1.50 |
ENST00000376837.3
|
C9orf41
|
chromosome 9 open reading frame 41 |
chr17_-_47785504 | 1.50 |
ENST00000514907.1
ENST00000503334.1 ENST00000508520.1 |
SLC35B1
|
solute carrier family 35, member B1 |
chr22_-_39096925 | 1.50 |
ENST00000456626.1
ENST00000412832.1 |
JOSD1
|
Josephin domain containing 1 |
chr17_-_49124230 | 1.50 |
ENST00000510283.1
ENST00000510855.1 |
SPAG9
|
sperm associated antigen 9 |
chrY_-_15591485 | 1.49 |
ENST00000382896.4
ENST00000537580.1 ENST00000540140.1 ENST00000545955.1 ENST00000538878.1 |
UTY
|
ubiquitously transcribed tetratricopeptide repeat containing, Y-linked |
chr6_-_42713792 | 1.49 |
ENST00000372876.1
|
TBCC
|
tubulin folding cofactor C |
chr6_+_35227449 | 1.48 |
ENST00000373953.3
ENST00000440666.2 ENST00000339411.5 |
ZNF76
|
zinc finger protein 76 |
chr7_+_44646218 | 1.47 |
ENST00000444676.1
ENST00000222673.5 |
OGDH
|
oxoglutarate (alpha-ketoglutarate) dehydrogenase (lipoamide) |
chr6_-_27440460 | 1.47 |
ENST00000377419.1
|
ZNF184
|
zinc finger protein 184 |
chr7_+_142494244 | 1.46 |
ENST00000390413.1
|
TRBJ2-2
|
T cell receptor beta joining 2-2 |
chr14_+_55738021 | 1.46 |
ENST00000313833.4
|
FBXO34
|
F-box protein 34 |
chr8_+_42552503 | 1.45 |
ENST00000534391.1
|
CHRNB3
|
cholinergic receptor, nicotinic, beta 3 (neuronal) |
chr18_+_61564389 | 1.45 |
ENST00000397996.2
ENST00000418725.1 |
SERPINB10
|
serpin peptidase inhibitor, clade B (ovalbumin), member 10 |
chr13_-_52378231 | 1.45 |
ENST00000280056.2
ENST00000444610.2 |
DHRS12
|
dehydrogenase/reductase (SDR family) member 12 |
chr16_+_68057179 | 1.45 |
ENST00000567100.1
ENST00000432752.1 ENST00000569289.1 ENST00000564781.1 |
DUS2
|
dihydrouridine synthase 2 |
chr6_-_24877490 | 1.44 |
ENST00000540914.1
ENST00000378023.4 |
FAM65B
|
family with sequence similarity 65, member B |
chr10_+_35484793 | 1.44 |
ENST00000488741.1
ENST00000474931.1 ENST00000468236.1 ENST00000344351.5 ENST00000490511.1 |
CREM
|
cAMP responsive element modulator |
chr19_-_42759266 | 1.44 |
ENST00000594664.1
|
AC006486.9
|
Uncharacterized protein |
chr8_-_116680833 | 1.43 |
ENST00000220888.5
|
TRPS1
|
trichorhinophalangeal syndrome I |
chr17_-_40540377 | 1.43 |
ENST00000404395.3
ENST00000389272.3 ENST00000585517.1 ENST00000588065.1 |
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
chrX_+_9431324 | 1.43 |
ENST00000407597.2
ENST00000424279.1 ENST00000536365.1 ENST00000441088.1 ENST00000380961.1 ENST00000415293.1 |
TBL1X
|
transducin (beta)-like 1X-linked |
chr11_+_122709200 | 1.43 |
ENST00000227348.4
|
CRTAM
|
cytotoxic and regulatory T cell molecule |
chr17_-_47785265 | 1.42 |
ENST00000511763.1
ENST00000515850.1 ENST00000415270.2 ENST00000240333.6 |
SLC35B1
|
solute carrier family 35, member B1 |
chr17_+_38497640 | 1.42 |
ENST00000394086.3
|
RARA
|
retinoic acid receptor, alpha |
chr1_-_93645818 | 1.42 |
ENST00000370280.1
ENST00000479918.1 |
TMED5
|
transmembrane emp24 protein transport domain containing 5 |
chr11_+_117049445 | 1.42 |
ENST00000324225.4
ENST00000532960.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr2_-_202645835 | 1.42 |
ENST00000264276.6
|
ALS2
|
amyotrophic lateral sclerosis 2 (juvenile) |
chr13_-_52378281 | 1.41 |
ENST00000218981.1
|
DHRS12
|
dehydrogenase/reductase (SDR family) member 12 |
chr15_-_73075964 | 1.41 |
ENST00000563907.1
|
ADPGK
|
ADP-dependent glucokinase |
chr19_-_50528584 | 1.40 |
ENST00000594092.1
ENST00000443401.2 ENST00000594948.1 ENST00000377011.2 ENST00000593919.1 ENST00000601324.1 ENST00000316763.3 ENST00000601341.1 ENST00000600259.1 |
VRK3
|
vaccinia related kinase 3 |
chr4_-_77997126 | 1.40 |
ENST00000537948.1
ENST00000507788.1 ENST00000237654.4 |
CCNI
|
cyclin I |
chr17_-_7155274 | 1.40 |
ENST00000318988.6
ENST00000575783.1 ENST00000573600.1 |
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr20_-_39317868 | 1.39 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
chr5_+_112849373 | 1.39 |
ENST00000161863.4
ENST00000515883.1 |
YTHDC2
|
YTH domain containing 2 |
chr5_-_175964366 | 1.39 |
ENST00000274811.4
|
RNF44
|
ring finger protein 44 |
chr7_+_120590803 | 1.39 |
ENST00000315870.5
ENST00000339121.5 ENST00000445699.1 |
ING3
|
inhibitor of growth family, member 3 |
chr9_+_125027127 | 1.39 |
ENST00000441707.1
ENST00000373723.5 ENST00000373729.1 |
MRRF
|
mitochondrial ribosome recycling factor |
chr16_+_85942594 | 1.39 |
ENST00000566369.1
|
IRF8
|
interferon regulatory factor 8 |
chr1_+_29213584 | 1.38 |
ENST00000343067.4
ENST00000356093.2 ENST00000398863.2 ENST00000373800.3 ENST00000349460.4 |
EPB41
|
erythrocyte membrane protein band 4.1 (elliptocytosis 1, RH-linked) |
chr19_-_47734448 | 1.38 |
ENST00000439096.2
|
BBC3
|
BCL2 binding component 3 |
chr14_+_60716159 | 1.38 |
ENST00000325658.3
|
PPM1A
|
protein phosphatase, Mg2+/Mn2+ dependent, 1A |
chr7_+_127228399 | 1.38 |
ENST00000000233.5
ENST00000415666.1 |
ARF5
|
ADP-ribosylation factor 5 |
chr17_-_7155802 | 1.37 |
ENST00000572043.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.8 | 5.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.8 | 5.3 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
1.2 | 3.5 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
1.1 | 3.2 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
1.0 | 4.8 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.9 | 4.7 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.9 | 2.7 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.9 | 2.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.8 | 3.4 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
0.8 | 3.4 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) |
0.8 | 2.5 | GO:0070510 | regulation of histone H4-K20 methylation(GO:0070510) positive regulation of histone H4-K20 methylation(GO:0070512) |
0.8 | 4.9 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.8 | 4.8 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) |
0.8 | 3.9 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.8 | 4.7 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.8 | 2.3 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
0.7 | 6.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.7 | 2.9 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.7 | 2.1 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.7 | 2.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.7 | 4.1 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.7 | 4.0 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.7 | 2.0 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
0.7 | 5.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.6 | 1.9 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.6 | 1.7 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.6 | 1.7 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.5 | 4.9 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.5 | 5.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.5 | 2.1 | GO:0045208 | MAPK phosphatase export from nucleus(GO:0045208) MAPK phosphatase export from nucleus, leptomycin B sensitive(GO:0045209) |
0.5 | 1.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.5 | 2.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 | 2.1 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
0.5 | 1.5 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.5 | 10.5 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.5 | 2.5 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.5 | 4.9 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.5 | 5.4 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 0.5 | GO:0090002 | establishment of protein localization to plasma membrane(GO:0090002) |
0.5 | 1.4 | GO:0071336 | submandibular salivary gland formation(GO:0060661) hair follicle cell proliferation(GO:0071335) regulation of hair follicle cell proliferation(GO:0071336) positive regulation of hair follicle cell proliferation(GO:0071338) |
0.5 | 1.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.5 | 1.8 | GO:0009386 | translational attenuation(GO:0009386) |
0.5 | 2.7 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 1.3 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.4 | 2.6 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.4 | 1.3 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.4 | 2.1 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.4 | 0.4 | GO:1903973 | negative regulation of macrophage colony-stimulating factor signaling pathway(GO:1902227) negative regulation of response to macrophage colony-stimulating factor(GO:1903970) negative regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903973) |
0.4 | 2.5 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.4 | 2.4 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.4 | 2.8 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.4 | 1.2 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.4 | 2.7 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 1.5 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.4 | 1.1 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) positive regulation of leukocyte tethering or rolling(GO:1903238) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.4 | 1.1 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.4 | 1.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.4 | 1.8 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.3 | 2.1 | GO:0032571 | response to vitamin K(GO:0032571) |
0.3 | 1.0 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.3 | 1.4 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.3 | 0.7 | GO:0048511 | rhythmic process(GO:0048511) |
0.3 | 1.3 | GO:0031081 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
0.3 | 3.6 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.3 | 0.3 | GO:2000458 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
0.3 | 1.9 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.3 | 4.7 | GO:0033227 | dsRNA transport(GO:0033227) |
0.3 | 4.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 0.9 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.3 | 1.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.3 | 1.5 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.3 | 3.2 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.3 | 0.3 | GO:0051604 | protein maturation(GO:0051604) |
0.3 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 1.1 | GO:1902269 | positive regulation of polyamine transmembrane transport(GO:1902269) |
0.3 | 1.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.3 | 2.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.3 | 2.5 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.3 | 1.1 | GO:0036483 | neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
0.3 | 0.8 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.3 | 1.1 | GO:0070845 | misfolded protein transport(GO:0070843) polyubiquitinated protein transport(GO:0070844) polyubiquitinated misfolded protein transport(GO:0070845) Hsp90 deacetylation(GO:0070846) |
0.3 | 0.8 | GO:1903450 | regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
0.3 | 1.1 | GO:0061358 | negative regulation of Wnt protein secretion(GO:0061358) |
0.3 | 0.8 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.3 | 1.1 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.3 | 0.8 | GO:0021503 | neural fold bending(GO:0021503) |
0.3 | 5.5 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.3 | 2.0 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.3 | 1.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 1.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.2 | 0.7 | GO:1901253 | regulation of intracellular transport of viral material(GO:1901252) negative regulation of intracellular transport of viral material(GO:1901253) |
0.2 | 1.7 | GO:0007079 | mitotic chromosome movement towards spindle pole(GO:0007079) |
0.2 | 0.7 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 1.0 | GO:0050993 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.2 | 1.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.2 | 0.5 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.2 | 1.1 | GO:2000566 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) |
0.2 | 1.6 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.2 | 0.9 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.2 | 1.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.2 | 1.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.2 | 2.0 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.2 | 0.6 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.2 | 1.5 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 3.2 | GO:0000050 | urea cycle(GO:0000050) |
0.2 | 2.1 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.2 | 0.6 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.2 | 2.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.4 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 0.6 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
0.2 | 0.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.2 | 1.6 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.2 | 0.4 | GO:0061184 | positive regulation of dermatome development(GO:0061184) |
0.2 | 1.0 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.2 | 1.6 | GO:0060702 | negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) |
0.2 | 2.2 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 0.6 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.2 | 1.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 2.5 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 1.2 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.2 | 0.6 | GO:2001258 | negative regulation of voltage-gated calcium channel activity(GO:1901386) negative regulation of high voltage-gated calcium channel activity(GO:1901842) negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.8 | GO:1903722 | regulation of centriole elongation(GO:1903722) |
0.2 | 1.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.2 | 2.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
0.2 | 0.6 | GO:0000967 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.2 | 0.9 | GO:0036511 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.2 | 0.7 | GO:2000174 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.2 | 0.6 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.2 | 0.6 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.2 | 0.5 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.2 | 1.5 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
0.2 | 3.9 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.2 | 1.1 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.2 | 2.5 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.7 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.2 | 1.0 | GO:2000503 | regulation of natural killer cell chemotaxis(GO:2000501) positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.2 | 0.9 | GO:0006051 | mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
0.2 | 3.1 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 2.6 | GO:0070072 | proton-transporting V-type ATPase complex assembly(GO:0070070) vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.2 | 0.7 | GO:1990637 | response to prolactin(GO:1990637) |
0.2 | 2.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.2 | 0.9 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.2 | 0.3 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 2.7 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.2 | 0.7 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.2 | 1.0 | GO:0001878 | response to yeast(GO:0001878) |
0.2 | 1.8 | GO:0046886 | positive regulation of hormone biosynthetic process(GO:0046886) |
0.2 | 1.6 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.2 | 1.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 2.0 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.2 | 2.6 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.2 | 0.2 | GO:1903659 | regulation of complement-dependent cytotoxicity(GO:1903659) |
0.2 | 1.3 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.2 | 2.4 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.2 | 0.8 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.2 | 4.5 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.2 | 0.5 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.2 | 0.2 | GO:1903378 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
0.2 | 1.1 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 0.6 | GO:1903912 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 0.9 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 1.2 | GO:0042303 | molting cycle(GO:0042303) hair cycle(GO:0042633) |
0.1 | 0.9 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 4.3 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.1 | 0.7 | GO:0060577 | pulmonary vein morphogenesis(GO:0060577) |
0.1 | 0.3 | GO:2000845 | testosterone secretion(GO:0035936) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.1 | 5.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 1.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.6 | GO:0055099 | detection of endogenous stimulus(GO:0009726) response to high density lipoprotein particle(GO:0055099) |
0.1 | 0.4 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.1 | 0.4 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.3 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.1 | 0.7 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 2.3 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 0.8 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.4 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 0.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 1.4 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 2.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.1 | 0.7 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 1.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.7 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.1 | 0.7 | GO:0061528 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.1 | 0.7 | GO:0006591 | ornithine metabolic process(GO:0006591) |
0.1 | 1.1 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.1 | 0.8 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.9 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 6.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.5 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.1 | 0.4 | GO:0031548 | regulation of brain-derived neurotrophic factor receptor signaling pathway(GO:0031548) |
0.1 | 0.7 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 2.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.8 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 1.4 | GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.1 | 1.9 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 0.4 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 1.0 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.5 | GO:0097068 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.1 | 0.4 | GO:0051102 | DNA ligation involved in DNA recombination(GO:0051102) |
0.1 | 0.5 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.4 | GO:0018364 | box C/D snoRNA 3'-end processing(GO:0000494) peptidyl-glutamine methylation(GO:0018364) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 0.9 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 0.4 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.1 | 0.6 | GO:0008203 | cholesterol metabolic process(GO:0008203) secondary alcohol metabolic process(GO:1902652) |
0.1 | 2.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 1.8 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.1 | 0.8 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.1 | 0.4 | GO:0002584 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
0.1 | 1.5 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.1 | 0.7 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.1 | 1.3 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.1 | 0.7 | GO:0010193 | response to ozone(GO:0010193) |
0.1 | 0.4 | GO:0000732 | strand displacement(GO:0000732) |
0.1 | 0.7 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.8 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.1 | 1.7 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.3 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.1 | 4.3 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.3 | GO:0042327 | positive regulation of phosphorylation(GO:0042327) |
0.1 | 0.7 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.9 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.1 | 0.6 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 0.5 | GO:0045324 | late endosome to vacuole transport(GO:0045324) |
0.1 | 2.6 | GO:0045835 | negative regulation of meiotic nuclear division(GO:0045835) |
0.1 | 0.4 | GO:0045829 | negative regulation of isotype switching(GO:0045829) |
0.1 | 0.8 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.1 | 0.5 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.3 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.1 | 0.8 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.1 | 1.9 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.1 | 0.2 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.1 | 0.4 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.1 | 0.3 | GO:0039020 | pronephric nephron morphogenesis(GO:0039007) pronephric nephron tubule morphogenesis(GO:0039008) pronephric nephron tubule development(GO:0039020) pronephric duct development(GO:0039022) pronephric duct morphogenesis(GO:0039023) Kupffer's vesicle development(GO:0070121) |
0.1 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.1 | 1.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.1 | 0.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.5 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 0.4 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.1 | 0.2 | GO:0039019 | pronephric nephron development(GO:0039019) |
0.1 | 0.6 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.1 | 1.4 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.1 | 0.4 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.1 | 0.8 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 1.0 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.7 | GO:0032202 | telomere assembly(GO:0032202) |
0.1 | 2.6 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.1 | 0.6 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 1.4 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.3 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.8 | GO:0039663 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 2.9 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.1 | 0.7 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.8 | GO:0009644 | response to high light intensity(GO:0009644) |
0.1 | 0.6 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 2.4 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 1.7 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.1 | 1.0 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
0.1 | 0.8 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.1 | 0.2 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.1 | 6.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.2 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
0.1 | 0.3 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.3 | GO:1902824 | cleavage furrow ingression(GO:0036090) lysosomal membrane organization(GO:0097212) positive regulation of late endosome to lysosome transport(GO:1902824) |
0.1 | 0.4 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 4.4 | GO:0014898 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 4.6 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.1 | 0.8 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.9 | GO:0045955 | negative regulation of calcium ion-dependent exocytosis(GO:0045955) |
0.1 | 0.7 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 0.4 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.4 | GO:0090156 | cellular sphingolipid homeostasis(GO:0090156) |
0.1 | 2.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 5.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.1 | 0.3 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.1 | 2.4 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 1.0 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.6 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.3 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
0.1 | 0.9 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.4 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.1 | 0.3 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 2.7 | GO:1904380 | endoplasmic reticulum mannose trimming(GO:1904380) |
0.1 | 0.3 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 2.7 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.1 | 0.8 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
0.1 | 0.8 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.7 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.3 | GO:1904338 | regulation of dopaminergic neuron differentiation(GO:1904338) |
0.1 | 0.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 0.3 | GO:0042823 | pyridoxal phosphate biosynthetic process(GO:0042823) |
0.1 | 0.3 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.1 | GO:0010628 | positive regulation of gene expression(GO:0010628) |
0.1 | 0.3 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.1 | 0.2 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.1 | 1.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 1.7 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.1 | 0.2 | GO:1900158 | negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.1 | 0.3 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 0.2 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.1 | 0.6 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.1 | 0.4 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.1 | 1.9 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.1 | 0.4 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
0.1 | 0.9 | GO:1901184 | regulation of epidermal growth factor receptor signaling pathway(GO:0042058) regulation of ERBB signaling pathway(GO:1901184) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 1.0 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) |
0.1 | 4.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.9 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 2.4 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 0.6 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.3 | GO:0006788 | heme oxidation(GO:0006788) |
0.1 | 2.7 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.8 | GO:0051350 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
0.1 | 1.5 | GO:0071850 | mitotic cell cycle arrest(GO:0071850) |
0.1 | 0.9 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.1 | 0.2 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.1 | 0.5 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.2 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.2 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.1 | 6.6 | GO:0030148 | sphingolipid biosynthetic process(GO:0030148) |
0.1 | 0.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.1 | 0.4 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
0.1 | 0.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.1 | 0.4 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.1 | 1.3 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.6 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.1 | 0.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.1 | 1.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.1 | 0.6 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 0.8 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.1 | 2.0 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.1 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.1 | 0.8 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.7 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.1 | 0.7 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.1 | GO:0060796 | regulation of transcription involved in primary germ layer cell fate commitment(GO:0060796) |
0.1 | 0.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.6 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.9 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.4 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.4 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 1.1 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.1 | 0.7 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.1 | 3.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.1 | 0.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.2 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 5.2 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 1.3 | GO:0046718 | viral entry into host cell(GO:0046718) |
0.1 | 0.8 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 1.6 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.8 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.1 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.4 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.5 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 1.1 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.1 | GO:0052501 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.1 | 0.7 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.5 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.1 | 1.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 1.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.7 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.1 | 0.6 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.1 | 0.3 | GO:0090649 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.3 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.1 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.1 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.1 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.1 | 0.5 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.1 | 1.3 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.1 | 0.4 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.1 | 1.6 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 1.1 | G |